(Press-News.org) RICHMOND, Va. (Aug. 3, 2011) – A single compound with dual function – the ability to deliver a diagnostic and therapeutic agent – may one day be used to enhance the diagnosis, imaging and treatment of brain tumors, according to findings from Virginia Commonwealth University and Virginia Tech.
Glioblastomas are the most common and aggressive brain tumor in humans, with a high rate of relapse. These tumor cells often extend beyond the well-defined tumor margins making it extremely difficult for clinicians and radiologists to visualize with current imaging techniques. Researchers have been investigating enhanced methods of attacking these cells in order to possibly delay or prevent brain tumor relapse.
In a study published in the August issue of the journal Radiology, the research team led by Panos Fatouros, Ph.D., a former professor and chair of the Division of Radiation Physics and Biology in the VCU School of Medicine who retired in 2010, demonstrated that a nanoparticle containing an MRI diagnostic agent can effectively be imaged within the brain tumor and provide radiation therapy in an animal model.
The nanoparticle filled with gadolinium, a sensitive MRI contrast agent for imaging, and coupled with radioactive lutetium 177 to deliver brachytherapy, is known as a theranostic agent – a single compound capable of delivering simultaneously effective treatment and imaging. The lutetium 177 is attached to the outside of the carbon cage of the nanoparticle.
"We believe the clustering properties of this nanoplatform prolong its retention within the tumor, thereby allowing a higher radiation dose to be delivered locally," said Michael Shultz, Ph.D., a research fellow in Fatouros' lab in the Department of Radiology in the VCU School of Medicine.
"This theranostic agent could potentially provide critical data about tumor response to therapy by means of longitudinal imaging without further contrast administration," said Fatouros.
A nanoparticle called a functionalized metallofullerene (fMF), also known as a "buckyball," served as the basis of this work and was created by study collaborator, Harry Dorn, Ph.D., a chemistry professor at Virginia Tech, and his team. In 1999, Dorn and his colleagues were able to encapsulate rare earth metals in the hollow interior of these nanoparticles that can easily be recognized by MRI techniques.
"Although this is a limited animal study, it shows great promise and hopefully this metallofullerene platform will be extended to humans," said Dorn.
###
Fatouros, who is the corresponding author on the study, Shultz and Dorn collaborated with John D. Wilson, Ph.D., associate professor in the VCU Department of Radiology; Christine E. Fuller, M.D., professor and director of neuropathology and autopsy pathology at VCU; and Jianyuan "Jason" Zhang, a graduate student in chemistry at Virginia Tech from Beijing, China.
The study was funded by grants to Fatouros from the National Institutes of Health's National Cancer Institute, and to Dorn from the National Science Foundation.
EDITOR'S NOTE: A copy of the study is available for reporters by email request from lbrooks@rsna.org.
About VCU and the VCU Medical Center: Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls more than 32,000 students in 211 certificate and degree programs in the arts, sciences and humanities. Sixty-nine of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.
Researchers develop and test new molecule as a delivery vehicle to image and kill brain tumors
2011-08-04
ELSE PRESS RELEASES FROM THIS DATE:
New study calls into question reliance on animal models in cardiovascular research
2011-08-04
Anyone who follows science has read enthusiastic stories about medical breakthroughs that include the standard disclaimer that the results were obtained in mice and might not carry over to humans.
Much later, there might be reports that a drug has been abandoned because clinical trials turned up unforeseen side effects or responses in humans. Given the delay, most readers probably don't connect the initial success and the eventual failure.
But Igor Efimov, PhD, a biomedical engineer at Washington University in St. Louis who studies the biophysical and physiological ...
Bellybutton microbiomes
2011-08-04
Public awareness about the role and interaction of microbes is essential for promoting human and environmental health, say scientists presenting research at the Ecological Society of America's (ESA) 96th Annual Meeting from August 7-12, 2011. Researchers shed light on the healthy microbes of the human body and other research on microbial and disease ecology to be presented at ESA's 2011 meeting in Austin, Texas.
Bellybutton microbiomes
Human skin is teeming with microbes—communities of bacteria, many of which are harmless, live alongside the more infamous microbes sometimes ...
Mold exposure during infancy increases asthma risk
2011-08-04
Infants who live in "moldy" homes are three times more likely to develop asthma by age 7—an age that children can be accurately diagnosed with the condition.
Study results are published in the August issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology (ACAAI).
"Early life exposure to mold seems to play a critical role in childhood asthma development," says Tiina Reponen, PhD, lead study author and University of Cincinnati (UC) professor of environmental health. "Genetic factors are also ...
US physicians spend nearly 4 times more on health insurance costs than Canadian counterparts
2011-08-04
ITHACA, N.Y. — U.S. physicians spend nearly $61,000 more than their Canadian counterparts each year on administrative expenses related to health insurance, according to a new study by researchers at Cornell University and the University of Toronto.
The study, published in the August issue of the journal Health Affairs, found that per-physician costs in the U.S. averaged $82,975 annually, while Ontario-based physicians averaged $22,205 – primarily because Canada's single-payer health care system is simpler.
Canadian physicians follow a single set of rules, but U.S. doctors ...
Group Health establishes major initiative to prevent opioid abuse and overdose
2011-08-04
SEATTLE—Fatal overdoses involving prescribed opioids tripled in the United States between 1999 and 2006, climbing to almost 14,000 deaths annually—more than cocaine and heroin overdoses combined. Hospitalizations and emergency room visits related to prescription opioid pain medicines such as oxycodone (brand name Oxycontin) and hydrocodone (Vicodin) also increased dramatically in the same period.
Now a report in the August issue of Health Affairs describes a major initiative at Group Health to make opioid prescribing safer while improving care for patients with chronic ...
Compression stockings may reduce OSA in some patients
2011-08-04
Wearing compression stockings may be a simple low-tech way to improve obstructive sleep apnea in patients with chronic venous insufficiency, according to French researchers.
"We found that in patients with chronic venous insufficiency, compression stockings reduced daytime fluid accumulation in the legs, which in turn reduced the amount of fluid flowing into the neck at night, thereby reducing the number of apneas and hypopnea by more than a third," said Stefania Redolfi, MD, of the University of Brescia in Italy, who led the research.
CVI occurs when a patient's veins ...
Gladstone scientist converts human skin cells into functional brain cells
2011-08-01
A scientist at the Gladstone Institutes has discovered a novel way to convert human skin cells into brain cells, advancing medicine and human health by offering new hope for regenerative medicine and personalized drug discovery and development.
In a paper being published online today in the scientific journal Cell Stem Cell, Sheng Ding, PhD, reveals efficient and robust methods for transforming adult skin cells into neurons that are capable of transmitting brain signals, marking one of the first documented experiments for transforming an adult human's skin cells into ...
Researchers target, switch off serotonin-producing neurons in mice
2011-08-01
Boston, MA (July 28, 2011) — Researchers have developed a toolkit that enables them to turn off targeted cell populations while leaving others unaffected.
Led by Susan Dymecki, a professor of genetics at Harvard Medical School, the group focused on serotonin-producing neurons, observing how mice behave in a normal environment when suddenly their serotonin neurons are turned down. While their findings affirm earlier studies, the researchers used a technique that is non-invasive and does not require anesthesia, surgeries, or knocking out a gene—each of which can cause ...
Shade & Shutter Expo Hires Markomm for Internet Marketing Services
2011-08-01
Shade & Shutter Expo and Markomm have entered into an agreement where Markomm, a SEO Denver Internet Marketing Firm, will provide PPC services to Shade & Shutter Expo. The multi layered campaign was launched July 21st in Myrtle Beach, SC and the surrounding areas. These campaigns will help Shade & Shutter Expo gain a stronger presence on the search engines, and result in more clients and sales.
Consumers today live in the information age. Technology has allowed consumers to have information at their fingertips and easily searchable through Google, Bing, Yahoo, ...
Strength in numbers
2011-08-01
New research sheds light on why, after 300,000 years of domination, European Neanderthals abruptly disappeared. Researchers from the University of Cambridge have discovered that modern humans coming from Africa swarmed the region, arriving with over ten times the population as the Neanderthal inhabitants.
The reasons for the relatively sudden disappearance of the European Neanderthal populations across the continent around 40,000 years ago has for long remained one of the great mysteries of human evolution. After 300 millennia of living, and evidently flourishing, ...